Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Address: Friedrichstraße 180, Berlin 10117,Germany
Tel: +49-(0)30 / 230 80 90
Web: http://www.iges.de/
IGES was founded in 1980 as a company for research and development in health-related matters; it also offers consultancy services. Its predecessor was the Berlin working group for structural research in health-related matters – Berliner Arbeitsgruppe Strukturforschung im Gesundheitswesen (BASiG) – an institution of the Berlin Technical University. Today it is Germany’s largest private R&D institute for health and healthcare.
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to…
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big…
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as…
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout…
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with…